Kestra Advisory Services’s Sagimet Biosciences SGMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$656K Hold
66,414
– – ﹤0.01% 2267
2026
Q2
$513K Hold
66,414
– – ﹤0.01% 2327
2026
Q1
$347K Buy
66,414
+400
+0.6% +$2.23K ﹤0.01% 2503
2025
Q4
$391K Buy
+66,014
New +$474K ﹤0.01% 2331

Other funds holding SGMT

Kestra Advisory Services's SGMT Position: Q3 2026 in Review

Kestra Advisory Services held its Sagimet Biosciences (SGMT) position steady in Q3 2026 at 66,414 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #2267.

Kestra Advisory Services first reported a position in SGMT in Q4 2025 and has held it in 4 quarters since. 153 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

  • Kestra Advisory Services held 66,414 shares of Sagimet Biosciences worth $656K as of Q3 2026.
  • Kestra Advisory Services left its Sagimet Biosciences share count unchanged in Q3 2026.
  • Sagimet Biosciences made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #2267 holding.
  • Kestra Advisory Services first reported a position in Sagimet Biosciences in Q4 2025 and has held it in 4 quarters since.
  • 153 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.